$70,000 of HALOZYME THERAPEUTICS INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to biopharmaceutical research, development, and manufacturing. Issues related to coverage and reimbursement."
You can find more data on corporate lobbying on Quiver Quantitative.
HALO Congressional Stock Trading
Members of Congress have traded $HALO stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HALO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 03/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HALO Insider Trading Activity
HALO insiders have traded $HALO stock on the open market 39 times in the past 6 months. Of those trades, 0 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $HALO stock by insiders over the last 6 months:
- HELEN TORLEY (PRESIDENT AND CEO) has made 0 purchases and 32 sales selling 226,569 shares for an estimated $15,866,732.
- CORTNEY CAUDILL (SVP, CHIEF OPERATING OFFICER) has made 0 purchases and 4 sales selling 33,120 shares for an estimated $2,233,064.
- BERNADETTE CONNAUGHTON has made 0 purchases and 3 sales selling 4,829 shares for an estimated $336,816.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HALO Hedge Fund Activity
We have seen 296 institutional investors add shares of HALO stock to their portfolio, and 300 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 1,842,956 shares (+inf%) to their portfolio in Q4 2025, for an estimated $124,030,938
- UBS GROUP AG removed 1,580,108 shares (-53.6%) from their portfolio in Q4 2025, for an estimated $106,341,268
- MACQUARIE GROUP LTD removed 1,546,185 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $104,058,250
- NORGES BANK added 1,039,354 shares (+120.1%) to their portfolio in Q4 2025, for an estimated $69,948,524
- D. E. SHAW & CO., INC. removed 1,000,909 shares (-37.8%) from their portfolio in Q4 2025, for an estimated $67,361,175
- MIZUHO MARKETS AMERICAS LLC added 926,526 shares (+270.8%) to their portfolio in Q4 2025, for an estimated $62,355,199
- MORGAN STANLEY added 920,699 shares (+53.0%) to their portfolio in Q4 2025, for an estimated $61,963,042
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HALO Analyst Ratings
Wall Street analysts have issued reports on $HALO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 01/08/2026
- HC Wainwright & Co. issued a "Buy" rating on 12/19/2025
To track analyst ratings and price targets for HALO, check out Quiver Quantitative's $HALO forecast page.
HALO Price Targets
Multiple analysts have issued price targets for $HALO recently. We have seen 7 analysts offer price targets for $HALO in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Mohit Bansal from Wells Fargo set a target price of $75.0 on 02/19/2026
- Robert Wasserman from Benchmark set a target price of $90.0 on 02/19/2026
- Brendan Smith from TD Cowen set a target price of $90.0 on 01/08/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $90.0 on 12/19/2025
- Graig Suvannavejh from Goldman Sachs set a target price of $56.0 on 11/18/2025
- Jason Butler from Citizens set a target price of $92.0 on 11/04/2025
- Jessica Fye from JP Morgan set a target price of $65.0 on 10/27/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
